Cargando…

Absence of HBV Reactivation in Patients With Resolved HBV Infection Following DAA Therapy for Hepatitis C: A 1-Year Follow-up Study

BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection and active or previous hepatitis B virus (HBV) are at risk of HBV reactivation (HBV-R) during direct-acting antiviral (DAA) therapy. Recent reports suggest that HBV-R may even occur several months after completion of DAA therapy. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mücke, Marcus M, Mücke, Victoria T, Peiffer, Kai-Henrik, Sarrazin, Christoph, Zeuzem, Stefan, Berger, Annemarie, Vermehren, Johannes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Editor's Choice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329904/ https://www.ncbi.nlm.nih.gov/pubmed/30648130 http://dx.doi.org/10.1093/ofid/ofy340

Ejemplares similares

Serum sphingolipid levels associate with upcoming virologic events and HBV genotype D in a cohort of patients with HBeAg-negative HBV infection
por: Mücke, Victoria Therese, et al.
Publicado: (2018)

Is DAA Treatment Associated with HBV Reactivation? Results from ERCHIVES
por: Butt, Adeel, et al.
Publicado: (2017)

Point Shear‐Wave Elastography Using Acoustic Radiation Force Impulse Imaging for the Prediction of Liver‐Related Events in Patients With Chronic Viral Hepatitis
por: Hernandez Sampere, Lisa, et al.
Publicado: (2020)

Hypopituitarism in Wilson’s disease resolved after copper-chelating therapy
por: Dauth, Nina, et al.
Publicado: (2021)

APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation
por: Kanda, Tatsuo, et al.
Publicado: (2019)

Association of Alpha-1 Antitrypsin Pi*Z Allele Frequency and Progressive Liver Fibrosis in Two Chronic Hepatitis C Cohorts
por: Mücke, Victoria Therese, et al.
Publicado: (2022)

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
por: Mücke, Marcus M., et al.
Publicado: (2019)

Vimentin S‐glutathionylation at Cys328 inhibits filament elongation and induces severing of mature filaments in vitro
por: Kaus‐Drobek, Magdalena, et al.
Publicado: (2020)

Behandlung von Hepatitis-C-Infektionen im Zeitalter direkt wirkender antiviraler Medikamente (DAAs)
por: Peiffer, Kai-Henrik, et al.
Publicado: (2022)

Quadruple mutation GCAC1809-1812TTCT acts as a biomarker in healthy European HBV carriers
por: Peiffer, Kai-Henrik, et al.
Publicado: (2020)

Impact of colonization with multidrug-resistant organisms on antibiotic prophylaxis in patients with cirrhosis and variceal bleeding
por: Mücke, Victoria T., et al.
Publicado: (2022)

Different Kinetics of HBV-DNA and HBsAg in HCV Coinfected Patients during DAAs Therapy
por: Colombatto, Piero, et al.
Publicado: (2022)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

The Predictive Role of Hepatitis B Biomarkers on HBV Reactivation following Direct-Acting Antiviral Therapy in HBV/HCV Coinfected Patients
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

Rituximab Administration and Reactivation of HBV
por: Tsutsumi, Yutaka, et al.
Publicado: (2010)

Evaluation of Point Shear Wave Elastography Using Acoustic Radiation Force Impulse Imaging for Longitudinal Fibrosis Assessment in Patients with HBeAg-Negative HBV Infection
por: Graf, Christiana, et al.
Publicado: (2019)

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: a case report
por: Mücke, Victoria Therese, et al.
Publicado: (2021)

Risk of HBV Reactivation in Patients With Resolved HBV Infection Receiving Anti-CD19 Chimeric Antigen Receptor T Cell Therapy Without Antiviral Prophylaxis
por: Li, Ping, et al.
Publicado: (2021)

Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma
por: Fujita, Misuzu, et al.
Publicado: (2022)

A Common HLA-DPA1 Variant Is Associated with Hepatitis B Virus Infection but Fails to Distinguish Active from Inactive Caucasian Carriers
por: Vermehren, Johannes, et al.
Publicado: (2012)

Prophylaxis of hepatitis B virus (HBV) infection reactivation – recommendations of the Working Group for prevention of HBV reactivation
por: Pawłowska, Małgorzata, et al.
Publicado: (2019)

Computational fluid dynamic analysis following recurrence of cerebral aneurysm after coil embolization
por: Irie, Keiko, et al.
Publicado: (2012)

Recent Advances in HBV Reactivation Research
por: Guo, Lixia, et al.
Publicado: (2018)

Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection
por: Tsai, Hsin-Ju, et al.
Publicado: (2023)

Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
por: Shields, Adrian M, et al.
Publicado: (2022)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
por: Lewis, Michael D, et al.
Publicado: (2014)

Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
por: Richter, Alex G., et al.
Publicado: (2021)

Incidence, risk factors, and clinical outcomes of HBV reactivation in non-liver solid organ transplant recipients with resolved HBV infection: A systematic review and meta-analysis
por: Yin, Saifu, et al.
Publicado: (2023)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy
por: Costantini, Andrea, et al.
Publicado: (2011)

Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments
por: Packer, John R., et al.
Publicado: (2019)

Prevalence and risk factors of hepatitis B virus reactivation in patients with solid tumors with resolved HBV infection
por: Kotake, Takeshi, et al.
Publicado: (2018)

Hepatitis B Virus (HBV) Reactivation Following Pharmacological Eradication of Hepatitis C Virus (HCV)
por: Pisaturo, Mariantonietta, et al.
Publicado: (2019)

ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage
por: Kostyusheva, Anastasiya, et al.
Publicado: (2019)

Type I interferon regulates cytokine‐delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression
por: Glennon‐Alty, L., et al.
Publicado: (2020)

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study
por: Shields, Adrian M, et al.
Publicado: (2021)

Normocalcaemic, vitamin D‐sufficient hyperparathyroidism – high prevalence and low morbidity in the general population: A long‐term follow‐up study, the WHO MONICA project, Gothenburg, Sweden
por: Kontogeorgos, Georgios, et al.
Publicado: (2015)

Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study
por: Hunyady, Peter, et al.
Publicado: (2022)

Better Glasgow outcome score, cerebral perfusion pressure and focal brain oxygenation in severely traumatized brain following direct regional brain hypothermia therapy: A prospective randomized study
por: Idris, Zamzuri, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dpl12d462057t6dp655d434cfs